Prostate cancer screening with MRI does not differ from PSA only for detection but reduces biopsies and overdiagnosis

被引:0
|
作者
Wilt, Timothy J. [1 ,2 ]
Dahm, Philipp [1 ,2 ]
机构
[1] Minneapolis VA Hlth Care Syst, Minneapolis, MN 55417 USA
[2] Univ Minnesota, Minneapolis, MN 55455 USA
关键词
D O I
10.7326/ANNALS-24-01275-JC
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Source Citation Fazekas T, Shim SR, Basile G, et al. Magnetic resonance imaging in prostate cancer screening: a systematic review and meta-analysis. JAMA Oncol. 2024;10:745-754. 38576242 Clinical Impact Ratings GIM/FP/GP: Public Health:
引用
收藏
页码:JC94 / JC94
页数:1
相关论文
共 50 条
  • [1] Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
    Franke, Katharina
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (06) : 279 - 280
  • [2] Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
    Morote, Juan
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (02): : 234 - 234
  • [3] Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
    Hugosson, Jonas
    Mansson, Marianne
    Wallstrom, Jonas
    Axcrona, Ulrika
    Carlsson, Sigrid V.
    Egevad, Lars
    Geterud, Kjell
    Khatami, Ali
    Kohestani, Kimia
    Pihl, Carl-Gustaf
    Socratous, Andreas
    Stranne, Johan
    Godtman, Rebecka Arnsrud
    Hellstrom, Mikael
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (23): : 2126 - 2137
  • [4] Bother during screening for prostate cancer with PSA followed by MRI and transrectal biopsies
    Godtman, Arnsrud R.
    Pettersson, C.
    Kollberg, Stinesen K.
    Wallstrom, J.
    Mansson, M.
    Hellstrom, M.
    Hugosson, J.
    EUROPEAN UROLOGY, 2022, 81 : S550 - S551
  • [5] The value of systematic biopsies in screening for prostate cancer with PSA followed by MRI - results from the GOTEBORG prostate cancer screening 2 trial
    Kohestani, K.
    Godtman, Arnsrud R.
    Axcrona, U.
    Egevad, L.
    Hellstrom, M.
    Khatami, A.
    Pihl, C-G
    Stranne, J.
    Wallstrom, J.
    Mansson, M.
    Carlsson, S., V
    Hugosson, J.
    EUROPEAN UROLOGY, 2022, 81 : S565 - S565
  • [6] Re: Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
    Bratt, Ola
    Auvinen, Anssi
    EUROPEAN UROLOGY, 2023, 83 (04)
  • [7] Re: Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
    Kenigsberg, Alexander P.
    Ahdoot, Michael
    Turkbey, Baris
    Pinto, Peter A.
    EUROPEAN UROLOGY, 2023, 83 (06) : 582 - 583
  • [8] The Impact of PSA Screening on Prostate Cancer Mortality and Overdiagnosis of Prostate Cancer in the United States
    Howrey, Bret T.
    Kuo, Yong-Fang
    Lin, Yu-Li
    Goodwin, James S.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2013, 68 (01): : 56 - 61
  • [9] Complications after transrectal ultrasound guided biopsies in screening for prostate cancer with PSA followed by MRI - results from the Goteborg prostate cancer screening 2 trial
    Kohestani, K.
    Godtman, Arnsrud R.
    Assadi, A.
    Eriksson, K.
    Stranne, J.
    Wallstrom, J.
    Hellstrom, M.
    Hugosson, J.
    EUROPEAN UROLOGY, 2022, 81 : S910 - S911
  • [10] MRI increases detection of prostate cancers and reduces overdiagnosis, finds study
    Mayor, Susan
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 360